title: OKT3-induced cytokine-release syndrome: occurrence beyond the second dose and association with rejection severity.
authors.affiliation: University of Illinois, Chicago 60612.
authors.forename: E M
authors.initials: EM
authors.lastname: Vasquez
authors.forename: A J
authors.initials: AJ
authors.lastname: Fabrega
authors.forename: R
authors.initials: R
authors.lastname: Pollak
mesh_terms: D016207:Cytokines / Q000378:metabolism*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology* / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D016853:Muromonab-CD3 / Q000009:adverse effects*; D012189:Retrospective Studies; D013577:Syndrome
chemical_list: D016207:Cytokines; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3